Search results
Emend is an antiemetic, a medicine that prevents nausea (feeling sick) and vomiting. Emend is used in patients aged from 6 months to prevent nausea and vomiting caused by chemotherapy (medicines used to treat cancer).
Emend is an antiemetic , a medicine that prevents nausea (feeling sick) and vomiting. Emend is used in patients aged from 6 months to prevent nausea and vomiting caused by chemotherapy (medicines used to treat cancer).
EMEND is given for 3 days as part of a regimen that includes a corticosteroid and a 5-HT3 antagonist. The recommended dose is 125 mg orally once daily one hour before start of chemotherapy on Day 1 and 80 mg orally once daily on Days 2 and 3 in the morning.
22 kwi 2024 · Expert Opinion. EMEND® 125 mg powder for oral suspension is the only licensed product containing aprepitant that is appropriate for paediatric patients under age 12. It has been reported that this product is in short supply in several of the member states in which it is licensed.
Dzieci i młodzież. Młodzież (w wieku od 12 do 17 lat) EMEND należy przyjmować przez 3 dni w skojarzeniu z antagonistą receptora 5-HT3. Zalecana dawka produktu leczniczego EMEND w postaci kapsułek wynosi 125 mg doustnie w 1. dniu oraz. 80 mg doustnie w 2. i 3. dniu.
2 wrz 2015 · EMEND is administered as part of a 3-day regimen for the prevention of nausea and vomiting associated with HEC or MEC in adults and pediatric patients 12 years of age and older and patients less than 12 years of age who weigh at least 30 kg, who can swallow oral capsules. The recommended dosage of EMEND is a 125-mg capsule given on Day 1 of
Classification of changes: questions and answers. This page is intended to provide advice to Marketing Authorisation Holders of centrally authorised medicinal products about classification of changes to the Marketing Authorisation post-authorisation and certain variation classification categories.
